Delivery Order SPE2DB22D1106-SPE2DB24FEKZ8
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor subsidiary of Amerisourcebergen Corporation, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a potential value of $1,113.28 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this specific award. This order is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S for a total ceiling value of $1,484.97. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a ceiling value of $1,172.13 and a period of performance through June 10, 2025. The contract is not set aside and was awarded on a competitive basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The award has a potential value of $1,487.60 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 10 mg/ml solution in 200 ml containers, with a ceiling value of $1,105.15. It is a firm fixed-price delivery order contract with a period of performance ending on July 16, 2025. The contract is not set-aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,181.88, is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. The contract appears to be part of a larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 200ml bottles of the pharmaceutical product VIMPAT 10 MG/ML Solution. The contract has a completion date of January 22, 2024 and a potential value of $1,604.36. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a $1,705.70 firm fixed price delivery order contract to provide VIMPAT 100 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of VIMPAT 10 mg/ml solution in a 200 ml quantity, valued at $1,964.65. This firm fixed-price delivery order, which is set to be completed by May 29, 2025, represents a pediatric or adjunctive treatment pharmaceutical for seizure management. The contract was competitively awarded with no set-aside designation and will be fulfilled from AmerisourceBergen Drug Corp's corporate office...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,662.19, is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of May 30, 2024 and is a firm fixed-price, delivery order type contract. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKZ8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product called VIMPAT 10 MG/ML SOLUTION 200ML. The contract, valued at $1,292.15, has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/11/24 |